SAFETY AND EFFICACY AT 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TDF USE

被引：0

作者：

Buti, Maria ^{[1
,2
]}

Lampertico, Pietro ^{[3
]}

Lim, Young-Suk ^{[4
]}

Agarwal, Kosh ^{[5
]}

Fung, Scott K. ^{[6
]}

Tsang, Owen ^{[7
]}

Elkhashab, Magdy ^{[8
]}

Kao, Jia-Horng ^{[9
]}

Luis Calleja, Jose ^{[10
]}

Khalili, Mandana ^{[11
]}

Ravendhran, Natarajan ^{[12
]}

Tan, Susanna ^{[13
]}

Flaherty, John F. ^{[13
]}

Gaggar, Anuj ^{[13
]}

Lau, Audrey H. ^{[13
]}

Wu, George ^{[13
]}

Hann, Hie-Won L. ^{[14
]}

Pan, Calvin ^{[15
]}

Kim, Hyung Joon ^{[16
]}

Kennedy, Patrick T. F. ^{[17
]}

Chan, Henry Lik Yuen ^{[18
]}

机构：

[1] Hosp Gen Univ Valle Hebron, Barcelona, Spain

[2] Ciberehd, Barcelona, Spain

[3] Univ Milan, Gastroenterol & Hepatol, Fdn Irccs Ca Granda O Maggiore Policlin, Milan, Italy

[4] Univ Ulsan, Dept Gastroenterol, Ctr Liver, Asan Med Ctr,Coll Med, Ulsan, South Korea

[5] Kings Coll Hosp London, Inst Liver Studies, London, England

[6] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada

[7] Princess Margaret Hosp, Kwai Chung, 2-10 Princess Margaret Hosp Rd, Hong Kong, Peoples R China

[8] Toronto Liver Ctr, Res, Toronto, ON, Canada

[9] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan

[10] Hosp Univ Puerta De Hierro, Majadahonda, Spain

[11] Univ Calif San Fransisco, San Francisco, CA USA

[12] Digest Dis Associates, Wyomissing, PA USA

[13] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[14] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[15] Calvin Q Pan Clin, New York, NY USA

[16] Chung Ang Univ, Coll Med, Seoul, South Korea

[17] Barts Hlth NHS Trust, London, England

[18] Chinese Univ Hong Kong, Hong Kong, Peoples R China

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

476

引用

页码：301A / 301A

页数：1